Nicole D Simpson, MD
Gastroenterology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Simpson’s office at (650) 254-5200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A76288 · Current
Licensed to practise in California · since 2001 · expires 2027-02-28 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$103,755
Medicare paid this office $103,755 for 430 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 176 | $40,865 | $231 |
| Return visit (30+ min) | 87 | $11,972 | $117 |
| Biopsy of large bowel using a flexible endoscope | 146 | $9,380 | $64 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 85 | $7,540 | $88 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $5,673 | $203 |
See all 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 176 | $40,865 | $231 |
| Return visit (30+ min) | 87 | $11,972 | $117 |
| Biopsy of large bowel using a flexible endoscope | 146 | $9,380 | $64 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 85 | $7,540 | $88 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $5,673 | $203 |
| Short return visit (20+ min) | 50 | $4,425 | $78 |
| Study of esophagus to assess movement | 16 | $3,777 | $236 |
| New patient visit (45+ min) | 20 | $3,142 | $157 |
| Long return visit (40+ min) | 20 | $2,914 | $146 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 207 | $962 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 46 | $702 | $15 |
Procedures Medicare counted
| Colonoscopy | 66 | More than 70% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 69 | More than 69% of doctors who do this |
Who their Medicare patients are
430 Original Medicare patients in 2024. Average age 73 · Under 65 5% · 85 and older 7% · Women 70% · Also on Medicaid 9% · Health risk score 0.91. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 56% · Diabetes 18% · Chronic kidney disease 18% · Coronary heart disease 15% · Cancer 15% · Depression 12% · Atrial fibrillation 11% · Heart failure 6% · Stroke 6% · COPD 3% · Dementia 3%.
The office billed $1,114,597, Medicare allowed $127,044 and paid $103,755; for 997 services of 39 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 430 | 997 | 73 | 0.91 | $1,114,597 | $103,755 |
| 2023 | 370 | 951 | 73 | 0.79 | $971,189 | $96,417 |
| 2022 | 344 | 854 | 74 | 0.84 | $812,177 | $84,730 |
| 2021 | 396 | 1,055 | 73 | 0.93 | $980,997 | $102,008 |
| 2020 | 364 | 1,007 | 74 | 1.06 | $876,848 | $86,836 |
| 2019 | 403 | 1,068 | 74 | 1.12 | $937,196 | $100,977 |
| 2018 | 383 | 1,225 | 73 | 1.05 | $878,328 | $97,341 |
| 2017 | 371 | 1,334 | 73 | 1.11 | $939,887 | $99,092 |
| 2016 | 326 | 741 | 72 | 1.02 | $688,289 | $77,480 |
| 2015 | 325 | 659 | 72 | 1.00 | $617,385 | $83,299 |
| 2014 | 315 | 693 | 73 | 0.98 | $636,470 | $86,887 |
| 2013 | 240 | 502 | 73 | 1.05 | $473,008 | $61,780 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 163 | $39,025 | $239 |
| Return visit (30+ min) | 76 | $11,974 | $116 |
| Biopsy of large bowel using a flexible endoscope | 147 | $10,122 | $68 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 68 | $6,028 | $87 |
| Long return visit (40+ min) | 22 | $4,303 | $172 |
| Short return visit (20+ min) | 43 | $3,538 | $77 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,058 | $204 |
| New patient visit (45+ min) | 17 | $2,141 | $126 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 217 | $1,090 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 56 | $878 | $16 |
2022: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 116 | $26,771 | $229 |
| Return visit (30+ min) | 77 | $10,915 | $120 |
| Biopsy of large bowel using a flexible endoscope | 122 | $8,256 | $68 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $5,887 | $87 |
| Long return visit (40+ min) | 35 | $5,763 | $165 |
| Short return visit (20+ min) | 38 | $3,921 | $85 |
| New patient visit (45+ min) | 25 | $3,557 | $142 |
| Study of esophagus to assess movement | 12 | $2,901 | $242 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,558 | $213 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 177 | $874 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 55 | $825 | $15 |
2021: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 132 | $31,009 | $235 |
| Return visit (30+ min) | 102 | $14,006 | $116 |
| Biopsy of large bowel using a flexible endoscope | 154 | $10,533 | $68 |
| New patient visit (45+ min) | 44 | $6,840 | $155 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $6,556 | $87 |
| Short return visit (20+ min) | 62 | $5,752 | $80 |
| Long return visit (40+ min) | 33 | $5,309 | $156 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,847 | $123 |
| Injection beneath lining of large bowel using a flexible endoscope | 100 | $1,487 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 187 | $918 | $5 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $819 | $63 |
2020: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 106 | $25,221 | $238 |
| Return visit (30+ min) | 115 | $13,100 | $97 |
| Biopsy of large bowel using a flexible endoscope | 138 | $11,034 | $80 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 64 | $5,287 | $78 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,399 | $212 |
| Short return visit (20+ min) | 36 | $2,545 | $65 |
| New patient visit (30+ min) | 22 | $2,309 | $105 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $2,254 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,171 | $128 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,796 | $75 |
| New patient visit (45+ min) | 12 | $1,568 | $131 |
| Injection beneath lining of large bowel using a flexible endoscope | 103 | $1,544 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 191 | $978 | $5 |
2019: 14 services
| Return visit (30+ min) | 162 | $20,440 | $97 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 88 | $20,338 | $229 |
| Biopsy of large bowel using a flexible endoscope | 146 | $15,441 | $104 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | $7,575 | $87 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,451 | $216 |
| New patient visit (45+ min) | 22 | $3,277 | $149 |
| Study of esophagus to assess movement | 14 | $2,626 | $188 |
| New patient visit (30+ min) | 25 | $2,464 | $99 |
| Short return visit (20+ min) | 40 | $2,374 | $58 |
| Long return visit (40+ min) | 17 | $2,149 | $126 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 13 | $2,113 | $163 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,726 | $123 |
| Injection beneath lining of large bowel using a flexible endoscope | 90 | $1,394 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 183 | $926 | $5 |
2018: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 85 | $18,264 | $215 |
| Return visit (30+ min) | 153 | $17,664 | $96 |
| Biopsy of large bowel using a flexible endoscope | 134 | $12,348 | $91 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 82 | $6,768 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $4,118 | $65 |
| Short return visit (20+ min) | 52 | $3,705 | $65 |
| New patient visit (30+ min) | 32 | $2,947 | $92 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,763 | $213 |
| Long return visit (40+ min) | 19 | $2,593 | $136 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,200 | $122 |
| New patient visit (45+ min) | 13 | $1,947 | $150 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 13 | $1,661 | $128 |
| Injection beneath lining of large bowel using a flexible endoscope | 86 | $1,324 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 79 | $1,140 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $944 | $34 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 185 | $909 | $5 |
2017: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 95 | $21,490 | $222 |
| Return visit (30+ min) | 120 | $16,049 | $96 |
| Biopsy of large bowel using a flexible endoscope | 166 | $15,896 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | $6,441 | $83 |
| New patient visit (30+ min) | 43 | $4,168 | $97 |
| New patient visit (45+ min) | 26 | $3,842 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,591 | $65 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,546 | $212 |
| Short return visit (20+ min) | 34 | $2,422 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,319 | $122 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 152 | $2,268 | $10 |
| Long return visit (40+ min) | 16 | $1,997 | $125 |
| Injection beneath lining of large bowel using a flexible endoscope | 95 | $1,819 | $19 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 181 | $785 | $4 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $656 | $33 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $218 | $10 |
2016: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 71 | $16,757 | $236 |
| Biopsy of large bowel using a flexible endoscope | 138 | $14,914 | $107 |
| Return visit (30+ min) | 92 | $11,287 | $93 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $5,913 | $79 |
| Short return visit (20+ min) | 45 | $3,471 | $63 |
| New patient visit (30+ min) | 39 | $3,295 | $84 |
| New patient visit (45+ min) | 23 | $3,281 | $143 |
| Long return visit (40+ min) | 14 | $1,759 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,093 | $99 |
| Injection beneath lining of large bowel using a flexible endoscope | 65 | $1,013 | $16 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $794 | $35 |
2015: 11 services
| Biopsy of large bowel using a flexible endoscope | 134 | $23,345 | $173 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 54 | $13,981 | $254 |
| Return visit (30+ min) | 75 | $9,887 | $99 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $5,056 | $84 |
| New patient visit (30+ min) | 51 | $4,658 | $91 |
| New patient visit (45+ min) | 30 | $4,404 | $147 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,915 | $243 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,638 | $120 |
| Short return visit (20+ min) | 35 | $2,440 | $64 |
| Injection beneath lining of large bowel using a flexible endoscope | 44 | $1,214 | $27 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $1,018 | $36 |
2014: 13 services
| Biopsy of large bowel using a flexible endoscope | 119 | $16,801 | $141 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 63 | $16,116 | $256 |
| Return visit (30+ min) | 69 | $8,233 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $6,162 | $91 |
| Short return visit (20+ min) | 57 | $4,379 | $61 |
| New patient visit (45+ min) | 31 | $4,114 | $133 |
| New patient visit (30+ min) | 37 | $3,690 | $100 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,890 | $241 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,191 | $122 |
| Long return visit (40+ min) | 15 | $1,770 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,089 | $64 |
| Injection beneath lining of large bowel using a flexible endoscope | 37 | $972 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $763 | $35 |
2013: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 45 | $10,826 | $241 |
| Biopsy of large bowel using a flexible endoscope | 80 | $10,759 | $134 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $6,189 | $109 |
| Return visit (30+ min) | 57 | $5,522 | $89 |
| Short return visit (20+ min) | 42 | $2,881 | $60 |
| New patient visit (45+ min) | 18 | $2,376 | $132 |
| New patient visit (30+ min) | 26 | $2,318 | $89 |
| Study of esophagus to assess movement | 11 | $1,946 | $177 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,208 | $86 |
| Injection beneath lining of large bowel using a flexible endoscope | 35 | $928 | $27 |
Drugs they prescribed that Part D paid
$59,453
Pharmacies billed $59,453 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 818) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
698 generic and 120 brand-name prescriptions · $59,453 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 14 | $7,279 | $520 |
| Sod Sulf-Potass Sulf-Mag Sulf | 107 | $7,146 | $67 |
| Dexlansoprazole Dr | 16 | $5,215 | $326 |
| Mesalamine | 20 | $4,471 | $224 |
| Omeprazole | 195 | $2,425 | $12 |
See all 15 drugs
| Linzess | 14 | $7,279 | $520 |
| Sod Sulf-Potass Sulf-Mag Sulf | 107 | $7,146 | $67 |
| Dexlansoprazole Dr | 16 | $5,215 | $326 |
| Mesalamine | 20 | $4,471 | $224 |
| Omeprazole | 195 | $2,425 | $12 |
| Ursodiol | 13 | $2,209 | $170 |
| Peg 3350-Electrolyte | 83 | $1,771 | $21 |
| Pantoprazole | 90 | $1,590 | $18 |
| Famotidine | 44 | $1,094 | $25 |
| Gavilyte-G | 48 | $675 | $14 |
| Gavilyte-C | 22 | $386 | $18 |
| Dicyclomine | 19 | $291 | $15 |
| Peg-3350 and Electrolytes | 18 | $277 | $15 |
| Sucralfate | 12 | $269 | $22 |
| Ondansetron Odt | 20 | $186 | $9 |
Year by year
| 2024 | 818 | 386 | 0% (0) | 15% | $59,453 |
| 2023 | 871 | 358 | 0% (0) | 18% | $83,987 |
| 2022 | 798 | 316 | 0% (0) | 23% | $92,972 |
| 2021 | 824 | 319 | 0% (0) | 29% | $116,736 |
| 2020 | 860 | 312 | 0% (0) | 27% | $185,840 |
| 2019 | 938 | 300 | 0% (0) | 27% | $169,397 |
| 2018 | 792 | 269 | 0% (0) | None | $188,666 |
| 2017 | 735 | 268 | 0% (0) | None | $93,197 |
| 2016 | 691 | 243 | 0% (0) | 36% | $179,104 |
| 2015 | 542 | 219 | 0% (0) | 49% | $94,030 |
| 2014 | 471 | 175 | None | 37% | $50,317 |
| 2013 | 341 | 120 | 0% (0) | 30% | $31,877 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Sod Sulf-Potass Sulf-Mag Sulf | 119 | $9,657 | $81 |
| Mesalamine | 19 | $8,407 | $442 |
| Dexlansoprazole Dr | 13 | $7,667 | $590 |
| Pantoprazole | 121 | $2,903 | $24 |
| Omeprazole | 211 | $2,666 | $13 |
| Budesonide Dr | 16 | $2,594 | $162 |
| Peg 3350-Electrolyte | 96 | $2,100 | $22 |
| Sucralfate | 22 | $2,063 | $94 |
| Famotidine | 49 | $1,128 | $23 |
| Enulose | 12 | $883 | $74 |
| Dicyclomine | 34 | $635 | $19 |
| Lansoprazole | 14 | $293 | $21 |
| Ondansetron Odt | 17 | $148 | $9 |
2022: 12 drugs
| Dexilant | 21 | $14,153 | $674 |
| Suprep | 72 | $8,164 | $113 |
| Pantoprazole | 137 | $3,142 | $23 |
| Omeprazole | 180 | $3,036 | $17 |
| Entecavir | 11 | $2,205 | $200 |
| Famotidine | 56 | $1,917 | $34 |
| Sod Sulf-Potass Sulf-Mag Sulf | 20 | $1,578 | $79 |
| Sucralfate | 26 | $1,556 | $60 |
| Peg 3350-Electrolyte | 66 | $1,316 | $20 |
| Budesonide Dr | 16 | $1,200 | $75 |
| Dicyclomine | 51 | $895 | $18 |
| Ondansetron Odt | 27 | $830 | $31 |
2021: 13 drugs
| Suprep | 132 | $14,642 | $111 |
| Dexilant | 24 | $9,585 | $399 |
| Pantoprazole | 126 | $3,903 | $31 |
| Omeprazole | 194 | $3,690 | $19 |
| Famotidine | 69 | $2,869 | $42 |
| Sucralfate | 16 | $2,195 | $137 |
| Budesonide Dr | 13 | $1,607 | $124 |
| Esomeprazole Magnesium | 15 | $1,085 | $72 |
| Dicyclomine | 33 | $467 | $14 |
| Ondansetron Odt | 18 | $336 | $19 |
| Peg 3350-Electrolyte | 17 | $260 | $15 |
| Gavilyte-C | 15 | $219 | $15 |
| Peg-3350 and Electrolytes | 16 | $188 | $12 |
2020: 17 drugs
| Xifaxan | 13 | $33,854 | $2,604 |
| Mesalamine | 15 | $19,373 | $1,292 |
| Dexilant | 32 | $12,128 | $379 |
| Suprep | 95 | $9,959 | $105 |
| Linzess | 22 | $9,856 | $448 |
| Omeprazole | 217 | $3,522 | $16 |
| Famotidine | 93 | $3,314 | $36 |
| Pantoprazole | 84 | $2,452 | $29 |
| Octreotide Acetate | 11 | $2,443 | $222 |
| Entecavir | 13 | $2,264 | $174 |
| Esomeprazole Magnesium | 17 | $1,605 | $94 |
| Sucralfate | 13 | $978 | $75 |
| Peg 3350-Electrolyte | 34 | $494 | $15 |
| Dicyclomine | 19 | $438 | $23 |
| Ondansetron Odt | 21 | $352 | $17 |
| Gavilyte-N | 22 | $338 | $15 |
| Gavilyte-C | 16 | $203 | $13 |
2019: 19 drugs
| Xifaxan | 22 | $51,732 | $2,351 |
| Dexilant | 47 | $26,594 | $566 |
| Suprep | 85 | $8,573 | $101 |
| Octreotide Acetate | 25 | $6,236 | $249 |
| Linzess | 12 | $5,145 | $429 |
| Pantoprazole | 126 | $2,999 | $24 |
| Entecavir | 23 | $2,839 | $123 |
| Omeprazole | 180 | $2,754 | $15 |
| Moviprep | 11 | $1,179 | $107 |
| Ranitidine | 95 | $1,088 | $11 |
| Esomeprazole Magnesium | 17 | $905 | $53 |
| Famotidine | 40 | $869 | $22 |
| Sucralfate | 18 | $768 | $43 |
| Gavilyte-C | 31 | $374 | $12 |
| Dicyclomine | 16 | $349 | $22 |
| Peg 3350-Electrolyte | 16 | $276 | $17 |
| Ondansetron Odt | 17 | $219 | $13 |
| Gavilyte-N | 15 | $194 | $13 |
| Furosemide | 11 | $22 | $2 |
2018: 14 drugs
| Xifaxan | 14 | $28,747 | $2,053 |
| Dexilant | 52 | $23,513 | $452 |
| Linzess | 18 | $8,767 | $487 |
| Amitiza | 18 | $8,116 | $451 |
| Suprep | 75 | $7,101 | $95 |
| Octreotide Acetate | 12 | $3,152 | $263 |
| Omeprazole | 157 | $1,826 | $12 |
| Pantoprazole | 115 | $1,605 | $14 |
| Esomeprazole Magnesium | 15 | $1,371 | $91 |
| Sucralfate | 35 | $1,187 | $34 |
| Peg 3350-Electrolyte | 50 | $884 | $18 |
| Ranitidine | 70 | $758 | $11 |
| Gavilyte-N | 27 | $434 | $16 |
| Dicyclomine | 19 | $228 | $12 |
2017: 14 drugs
| Dexilant | 44 | $16,413 | $373 |
| Amitiza | 20 | $7,127 | $356 |
| Suprep | 75 | $6,635 | $88 |
| Esomeprazole Magnesium | 20 | $5,007 | $250 |
| Linzess | 12 | $4,328 | $361 |
| Octreotide Acetate | 13 | $3,511 | $270 |
| Omeprazole | 154 | $1,830 | $12 |
| Pantoprazole | 75 | $1,266 | $17 |
| Peg 3350-Electrolyte | 63 | $966 | $15 |
| Sucralfate | 23 | $928 | $40 |
| Gavilyte-N | 26 | $444 | $17 |
| Dicyclomine | 33 | $361 | $11 |
| Ranitidine | 39 | $352 | $9 |
| Propranolol | 11 | $46 | $4 |
2016: 12 drugs
| Dexilant | 70 | $21,419 | $306 |
| Linzess | 11 | $6,084 | $553 |
| Nexium | 17 | $5,825 | $343 |
| Omeprazole | 157 | $2,180 | $14 |
| Suprep | 25 | $2,055 | $82 |
| Pantoprazole | 56 | $1,195 | $21 |
| Peg 3350-Electrolyte | 72 | $1,097 | $15 |
| Gavilyte-N | 27 | $426 | $16 |
| Ranitidine | 28 | $344 | $12 |
| Dicyclomine | 31 | $224 | $7 |
| Polyethylene Glycol 3350 | 11 | $79 | $7 |
| Furosemide | 12 | $18 | $1 |
2015: 11 drugs
| Dexilant | 73 | $19,148 | $262 |
| Linzess | 21 | $5,955 | $284 |
| Amitiza | 12 | $5,518 | $460 |
| Omeprazole | 131 | $2,080 | $16 |
| Moviprep | 25 | $2,005 | $80 |
| Ursodiol | 17 | $1,976 | $116 |
| Peg 3350-Electrolyte | 68 | $1,189 | $17 |
| Suprep | 13 | $1,067 | $82 |
| Pantoprazole | 17 | $489 | $29 |
| Gavilyte-N | 18 | $343 | $19 |
| Dicyclomine | 20 | $184 | $9 |
2014: 9 drugs
| Dexilant | 32 | $11,148 | $348 |
| Amitiza | 11 | $3,724 | $339 |
| Moviprep | 43 | $3,370 | $78 |
| Omeprazole | 132 | $2,161 | $16 |
| Pantoprazole | 41 | $619 | $15 |
| Peg-3350 | 29 | $504 | $17 |
| Spironolactone | 14 | $183 | $13 |
| Dicyclomine | 12 | $106 | $9 |
| Furosemide | 12 | $47 | $4 |
2013: 4 drugs
| Dexilant | 23 | $7,128 | $310 |
| Omeprazole | 116 | $2,114 | $18 |
| Moviprep | 24 | $1,745 | $73 |
| Pantoprazole | 56 | $858 | $15 |
Money from drug and device companies
$33 in 2025
| 2025 | 2 | 2 | None | $33 |
| 2024 | 2 | 2 | None | $77 |
| 2023 | 1 | 1 | None | $143 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Micro-tech Endoscopy USA | Lockado | $19 | 1 payment
|
| Conmed | Conmed Biliary | $14 | 1 payment
|
See all 2 published payments
| Micro-tech Endoscopy USA | Meals · 2025-10-04 | Lockado | $19 |
| Conmed | Meals · 2025-10-04 | Conmed Biliary | $14 |
See earlier years (2024, 2023)
2024: $77
| Medtronic | Nexpowder | $65 | 1 payment
|
| Micro-tech Endoscopy USA | Eyemx | $12 | 1 payment
|
2023: $143
| Medtronic | Prodigi | $143 | 1 payment
|
Professional record
- NPI
- 1497798904
- Licence
- CA A76288California A76288: Current · expires 2027-02-28
- Trained
- Stanford University School of Medicine, 2000
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-06-13
- NPI last updated
- 2011-12-05
This is when the NPI record was last certified, not a medical board exam.